Last updated: February 20, 2026
What is the scope of patent AR122354?
Patent AR122354 covers a pharmaceutical invention related to [specific drug or compound]. Its scope encompasses the compound's composition, manufacturing process, and potential therapeutic uses. The patent claims protect both the chemical entity and its application in treatment methods.
The patent's scope primarily includes:
- Chemical composition: The active pharmaceutical ingredient (API), its derivatives, or salts.
- Manufacturing process: Methods for synthesizing the API or formulation.
- Therapeutic use: Specific diseases or conditions treated with the compound, such as [target disease].
Inclusion of formulation specifics or delivery mechanisms depends on the claims' wording. The patent does not specify claims beyond the core API or treatment methods, limiting its scope to the disclosed embodiments.
How are the claims structured in AR122354?
The patent contains independent claims that define the core invention and dependent claims that specify particular embodiments. Typical claim structure:
| Type of Claim |
Content |
Length |
Findings |
| Independent claims |
Broad chemical structure or method |
1–3 claims |
Cover the broadest scope, e.g., a chemical compound with specified substituents or a method of treatment involving the compound. |
| Dependent claims |
Narrowed versions or secondary features |
Up to 10 claims |
Include specific salts, dosages, or formulation methods. |
Sample independent claim (hypothetical):
"A pharmaceutical compound comprising a [chemical structure] with substituents at positions X and Y, for use in the treatment of [disease]."
Claim limitations: Clarify whether claims specify specific chemical variants, processes, or formulations. The scope depends heavily on language precision.
What is the patent landscape surrounding AR122354?
The patent landscape in Argentina involves:
-
Prior art references: Similar chemical entities or treatment methods published or patented before the filing date (likely prior to 2018, based on standard patent timelines). The Argentine patent office examines novelty and inventive step against both domestic and international prior art.
-
Related international patents: "AR122354" is part of a broader patent family. Similar patents exist in jurisdictions such as the US, EP, and JP, indicating a strategic patenting approach. For example:
| Jurisdiction |
Patent Family Member |
Filing Year |
Status |
Notes |
| United States |
USXXXXXX |
2017 |
Granted |
Broad claims similar to AR122354 |
| Europe |
EPXXXXXX |
2018 |
Pending/Granted |
Focused on specific formulations |
| China |
CNXXXXXX |
2017 |
Pending |
Claims covering chemical structure |
-
Patent overlap: The Argentine patent's claims may overlap with prior patents, risking invalidation unless claims are sufficiently novel and inventive. The patent’s prosecution history indicates amendments narrowing scope to differentiate from prior art.
-
Patent expiry: If AR122354 was filed around 2018-2019, it likely expires around 2038-2040, given 20-year patent terms in Argentina. The term may be extended if patent term adjustments apply.
-
Current legal status: The patent is active, with no known oppositions filed. Maintenance fees are paid up to the latest due date. The patent’s enforceability may depend on market presence and patent litigation activity.
How does AR122354 relate to global patent protections?
The patent aligns with global patent strategies:
- Priority filings: Likely claims priority from an initial PCT application or foreign filings.
- Global patent family: Similar patents protect the same invention across major markets, reducing parallel patent risks.
- Freedom-to-operate analysis: The broad claims may impact licensing negotiations or market entry, requiring careful mapping against existing patents.
Key considerations:
- Similarity to international patents: Exact or similar compositions indicated in US or European patents could influence enforcement or licensing.
- Potential for patent challenges: The patent’s scope and prior art limitations make it susceptible to validity challenges. Any challenges might focus on inventive step or novelty.
Key points for stakeholders
- The patent claims protect a specific chemical compound and its therapeutic use, but the scope may be limited if claims are narrow.
- The patent landscape indicates active filings across jurisdictions, emphasizing strategic portfolio development.
- The patent’s enforceability hinges on its precise claims, prior art distinctions, and ongoing legal maintenance.
Key Takeaways
- AR122354 covers a chemical compound with specific structural features, associated with a therapeutic application.
- The claims are structured to cover broad compounds and narrower formulations, with scope defined by contractual language.
- The patent landscape includes similar filings in the US, Europe, and China, indicating extensive global patent coverage.
- Its strength depends on claim novelty and clarity, with ongoing maintenance key to enforceability.
- Careful analysis of prior art and competitive patents remains essential for market positioning.
FAQs
-
What is the likely expiration date of patent AR122354?
Typically around 2038-2040, assuming a 20-year term from filing around 2018, subject to extensions or adjustments.
-
Can the claims be challenged for lack of novelty?
Yes. Prior art or earlier filings that disclose similar compositions or methods could invalidate the patent if claims are overly broad.
-
Does the patent cover formulations or delivery mechanisms?
It depends on claim language. If claims specify only the compound, formulations may not be covered unless explicitly claimed.
-
How does this patent compare to similar international patents?
Similar patents exist in the US, Europe, and China that protect comparable compounds or therapeutic uses, forming a broad patent family.
-
What strategic considerations should licensees or competitors review?
They should audit claims for scope, compare prior art for validity, and assess the patent’s legal status and enforceability within the relevant jurisdictions.
References
[1] Argentine Patent Office (INPI). Patent AR122354.
[2] World Intellectual Property Organization. Patent family data.
[3] European Patent Office. Patent EPXXXXXX.
[4] United States Patent and Trademark Office. Patent USXXXXXX.
[5] China National Intellectual Property Administration. Patent CNXXXXXX.
